Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,701.00
Ask: 1,701.50
Change: 32.00 (1.91%)
Spread: 0.50 (0.029%)
Open: 1,685.50
High: 1,718.50
Low: 1,673.00
Prev. Close: 1,673.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Women struggling to crack glass ceiling in top UK companies-report

Wed, 26th Mar 2014 15:17

* Women now hold fifth of FTSE 100 board positions

* Few women on executive committees with only 4 CEOs

* Campaigners push for voluntary change, not quotas (Adds new quotes, numbers, after report launch)

By Belinda Goldsmith

LONDON, March 26 (Reuters) - More women are sitting on theboards of Britain's blue-chip companies but the glass ceilingis yet to crack, with most top jobs still held by men andcompanies needing to do more to promote women, a governmentreport said on Wednesday.

The third annual progress report found women now occupy afifth, or 20.7 percent, of positions in FTSE 100 companies, upfrom 12.5 percent in 2011, within striking distance of a targetfor women to account for one quarter of board seats by 2015.

But campaigners admitted there was still a long way to go aswomen only account for 6.9 percent of senior executive roles inthe FTSE 100 where there are only four women chief executives.

Two companies in the FTSE 100, commodities trader GlencoreXstrata and miner Antofagasta, still haveall-male boards - although they told Reuters they are seekingfemale directors - and 48 FTSE 250 companies have all-maleboards.

Former trade minister Mervyn Davies, leader of thegovernment initiative since 2011, said the figures showed avoluntary drive to boost women around the boardroom table wasworking and ruled out the need for mandatory quotas such asthose introduced in France, Italy, Spain and the Netherlands andplanned for Germany.

He said the key to lasting improvement was encouragingcompanies to drive change within, not legislation or governmentintervention that critics argue can lead to tokenism and "trophydirectors".

"This is about changing the culture of corporate Britain,and using a stick is not the best way to do that," Davies toldReuters after launching the latest report in London.

"Everyone now sees that (having more women on boards) isgreat business sense so the debate is now moving from theboardroom to executive committees."

BUSINESS CREDIBILITY

He said Britain was leading the way at driving corporatechange on a voluntary basis rather than with quotas which arenow being mulled in the European Union.

But he said companies whether public or private had to stepup to the mark and he has written to all companies in the FTSE350 urging them to find ways to boost female representation.

"Failure would again raise the unwelcome proposal ofcompulsory measures. British business credibility is at stakeand we need to redouble our efforts," Davies said.

Minister for Women Maria Miller said companies needed to behonest that the culture in Britain was not neutral and it wasstill "white, male and heterosexual".

The only FTSE 100 female CEOs are Moya Greene at Royal Mail, Carolyn McCall at easyJet, Angela Ahrendts atBurberry and Alison Cooper at Imperial Tobacco.

Capita and Diageo had the highest proportionof women among FTSE 100 boards at 44 percent, followed by RoyalMail, Unilever, and GlaxoSmithKline.

Miller said corporate change was needed to address genderimbalance as well as the pay gap between men and women and ruleson executive pay.

"Women don't need special treatment. They just need an equalplaying field," she said.

With the spotlight on promoting women, several British banksreleased targets on gender balance in their annual results forthe first time this year.

HSBC aims to have women in 25 percent of seniorroles by 2014/15, up from 22.7 percent; Lloyds has atarget of 40 percent by 2020 compared to 28 percent now; andBarclays is eyeing 26 percent by 2018, up 5 points.

Davies, the former chief executive of Standard Chartered, said it was "inconceivable in this day and age" tohave an all-male board or executive committee.

"A company that does not get the mood of society on thisissue actually deserves to go out of business," he said. (Additional reporting by Steve Slater, Editing by AlisonWilliams)

More News
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.